Loading chat...

CO SB066

Bill

Status

Failed

2/26/2025

Primary Sponsor

Paul Lundeen

Click for details

Origin

Senate

2025 Regular Session

AI Summary

  • Colorado Department of Public Health and Environment must contract with opioid antagonist medication distributors for bulk purchasing and distribution of FDA-approved opioid antagonists (e.g., naloxone)

  • Distributors are prohibited from receiving state contracts if they were found liable, settled claims, or paid fines/penalties related to manufacturing or distributing opioids that resulted in overdose events

  • The prohibition extends to any division, subsidiary, parent, affiliate, or related entity under common ownership or control of a company with opioid liability

  • Department must implement a competitive selection process under the state Procurement Code, with distributors required to demonstrate eligibility and department required to verify compliance

  • Any contract violating these requirements is void and unenforceable as contrary to state public policy; selection process records become public after contract award

Legislative Description

State Contracts with Opioid Antagonist Businesses

Public Health

Last Action

Senate Committee on Health & Human Services Postpone Indefinitely

2/26/2025

Committee Referrals

Health and Human Services1/22/2025

Full Bill Text

No bill text available